Biden Strengthens Protections for LGBTQ Health Care
The Biden Administration announced Monday it will interpret federal non-discrimination provisions as protecting the LGBTQ community against discrimination in health care.
The move, which was announced through the Department of Health and Human Services, means the Office for Civil Rights will interpret and enforce Section 1557 and Title IX’s prohibitions on discrimination based on sex to include discrimination on the basis of sexual orientation and discrimination on the basis of gender identity.
“Fear of discrimination can lead individuals to forgo care, which can have serious negative health consequences. It is the position of the Department of Health and Human Services that everyone, including LGBTQ people, should be able to access health care, free from discrimination or interference, period,” said the U.S. Department of Health and Human Services Secretary Xavier Becerra in a written statement.
The administration’s decision reverses a Trump-era policy that eliminated explicit protections from discrimination based on sex stereotyping and gender identity, thereby sanctioning discrimination against LGBTQ people, such as allowing for insurance policies and health care regulated under the Affordable Care Act to deny services to transgender people.
The move also restored an Obama-era policy which applied protections to transgender and gay people under the Affordable Care Act.
According to a recent Gallup survey, nearly 5.6% of the population currently identify as lesbian, gay, bisexual or transgender, and the US Department of Health and Human Services said that currently 25 percent of LGBTQ people who have faced discrimination postponed or avoided receiving necessary medical care because they feared further discrimination.
Studies show that 56% of LGB people and 70% of transgender and gender non-conforming people reported experiencing discrimination by health care providers, including refusal of care, harsh language and physical roughness because of their sexual orientation or gender identity.
According to a report by the National Center for Transgender Equality, 23% of transgender respondents did not see a doctor when they needed to because of fear of being mistreated as a transgender person and 55% of transgender respondents who sought coverage for transition-related surgery were denied.
In The News
Vaccine maker Novavax said Monday its COVID-19 shot was highly effective against the disease and also protected against variants in a large study in the U.S. and Mexico, potentially offering the world yet another weapon against the virus at a time when developing countries are desperate... Read More
CAPE TOWN, South Africa (AP) — U.S. plans to donate 500 million more COVID-19 vaccines to developing countries were met Thursday with both celebration and hesitation amid questions over whether the effort will be enough to help poor regions desperate for doses. Some health officials and... Read More
The FDA has authorized the first aid for diagnosing Autism Spectrum Disorder in children 18 months through 5 years of age called Canvas Dx. It was developed by Cognoa, a behavioral health company. “Currently, pediatricians refer most children with suspected developmental delay to specialists to diagnose... Read More
Why do some people get side effects after COVID-19 vaccines? Temporary side effects including headache, fatigue and fever are signs the immune system is revving up -- a normal response to vaccines. And they're common. "The day after getting these vaccines, I wouldn't plan anything that... Read More
Rep. Tom O’Halleran, D-Ariz., has joined Rep. Jodey Arrington, R- Texas, and a bipartisan group of members in a drive to improve the performance standards for health care providers who participate in Medicare’s Accountable Care Organizations, which are part of the Medicare Shared Savings Program. “For... Read More
The Supreme Court this week decided to leave in place a $2 billion verdict in favor of women who claim they developed ovarian cancer from using Johnson & Johnson talc products. As is their custom, the justices did not comment Tuesday on why they rejected Johnson & Johnson's... Read More